SCHEMBL23950884

SCHEMBL23950884

CC1(C)c2ccccc2-c2ccc(N(c3cccc(-c4ccc5ccccc5c4)c3)c3cccc4c3-c3ccccc3C4(C)C)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
SLC6A2 P23975 1/20 0.32
CHRNB4 P30926 1/20 0.32
SLC6A4 P31645 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CHRND Q07001 1/20 0.32
LPL P06858 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
PDK2 Q15119 4/20 0.31
HDAC4 P56524 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
AKT1 P31749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23951110 0.96 PDK2 (0.33) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL22425196 0.95 HSD17B1 (0.32) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL23951228 0.94 LPL (0.34) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL23950948 0.94 PDK2 (0.35) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL26002066 0.93 LPL (0.35) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL26002052 0.93 LPL (0.35) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL26002026 0.93 LPL (0.35) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL26002058 0.93 LPL (0.36) HSD17B1HSD17B2CHRNA1CHRNGCHRNB1
SCHEMBL26154324 0.92 LPL (0.31) HSD17B1HSD17B2LPLLIPGPDK2
SCHEMBL23950924 0.92 PDK2 (0.34) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12048239-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2024-07-23 US disclosed
US-12048239-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2024-07-23 US disclosed
US-20220149295-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2022-05-12 US disclosed
US-20210328144-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220149295-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OCIAD2, OR10J3, OCIAD1 HSD17B1 1143/4885HSD17B2 1078/4885CHRNA1 1264/4885
US-20210328144-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 HSD17B1 1080/4885HSD17B2 926/4885CHRNA1 1276/4885
US-12048239-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device OR10J3, OCIAD2, OCIAD1 HSD17B1 1080/4885HSD17B2 926/4885CHRNA1 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.